课题基金 / 基金详情

SIGNALING OF APOPTOSIS IN CANCER

SIGNALING OF APOPTOSIS IN CANCER
癌症中细胞凋亡的信号
批准号:
6173269
负责人:
Glenn D. Rosen
金额:
$20.21万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-08-01 至 2002-07-31

项目摘要

项目成果

Glenn D. Rosen的其他基金

相似基金

相关文献

中文摘要
翻译
描述:最近的研究表明,肿瘤细胞比 比正常细胞对成员诱导的凋亡信号敏感 肿瘤坏死因子家族的成员,称为肿瘤坏死因子相关的细胞凋亡- 诱导配体(TRAIL),也称为载脂蛋白2L。申请人已作出 几个有趣的观察结果,包括:(I)干扰素- Gamma)增敏A549、HT1090和ME180癌细胞对载脂蛋白2L的诱导 细胞凋亡;(Ii)转录因子的表达,INF调节 干扰素-γ也能在这些细胞中诱导因子(IFR-1);(Iii) Apo2L途径的激活激活了特定的caspase,从而诱导 对p120/RAS GTP酶的切割;以及(Iv)地塞米松是一种有效的 载脂蛋白2L诱导细胞死亡的抑制剂。此应用程序的目标是 研究肿瘤细胞中TRAIL/Apo2L通路并确定部分 TRAIL/Apo2L信号通路可能导致更好的 了解细胞如何杀伤肿瘤细胞的机制 发生。提出了三个具体目标:(I)审查 IRF-1调节肿瘤细胞增敏的机制 干扰素-γ对载脂蛋白2L诱导的细胞凋亡的影响 在载脂蛋白2L诱导的细胞凋亡过程中caspase介导的ras间隙的裂解; 以及(Iii)确定地塞米松在 载脂蛋白2L途径。
英文摘要
DESCRIPTION: Recent studies have demonstrated that tumor cells are more sensitive than normal cells to an apoptotic signal induced by a member of the tumor necrosis factor (TNF) family called TNF-related apoptosis- inducing ligand (TRAIL) also known as Apo2L. The applicant has made several interesting observations, including: (i) interferon gamma (INF- gamma) sensitizes A549, HT1090 and ME180 cancer cells to Apo2L-induced apoptosis; (ii) expression of transcription factor, INF regulatory factor (IFR-1), is also induced in these cells by INF-gamma; (iii) activation of Apo2L pathway activates specific caspases that induces cleavage of p120/Ras GTPase; and (iv) dexamethasone is a potent inhibitor of Apo2L-induced cell death. The goal of this application is to investigate the TRAIL/Apo2L pathway in tumor cells and define parts of the TRAIL/Apo2L signaling pathway that may lead to a better understanding the mechanisms underlying how cell killing of tumor cells occurs. Three Specific Aims are proposed: (I) to examine the mechanisms by which IRF-1 regulates the sensitization of tumor cells by IFN-gamma to the Apo2L-induced apoptosis; (II) to characterize the role of caspase-mediated cleavage of ras GAP during Apo2L-induced apoptosis; and (III) to determine the targets of dexamethasone's actions in the Apo2L pathway.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
JUN Kinase Signaling in the Lung
  • 批准号:
    7092061
  • 项目类别:
  • 资助金额:
    $35.15万
  • 财政年份:
    2003
  • 负责人:
    Glenn D. Rosen
  • 依托单位:
JUN Kinase Signaling in the Lung
  • 批准号:
    6684629
  • 项目类别:
  • 资助金额:
    $34.74万
  • 财政年份:
    2003
  • 负责人:
    Glenn D. Rosen
  • 依托单位:
JUN Kinase Signaling in the Lung
  • 批准号:
    6901828
  • 项目类别:
  • 资助金额:
    $36.0万
  • 财政年份:
    2003
  • 负责人:
    Glenn D. Rosen
  • 依托单位:
JUN Kinase Signaling in the Lung
  • 批准号:
    6787277
  • 项目类别:
  • 资助金额:
    $36.0万
  • 财政年份:
    2003
  • 负责人:
    Glenn D. Rosen
  • 依托单位:
海外基金